Opportunity and challenge of clinical biobank in China
CSTR:
Author:
Affiliation:

Department of Biobank,Pediatric Translational Medicine Institute,Shanghai Children's Medical Center,Shanghai Jiaotong University School of Medicine,Department of Biobank,Pediatric Translational Medicine Institute,Shanghai Children's Medical Center,Shanghai Jiaotong University School of Medicine,Department of Biobank,Pediatric Translational Medicine Institute,Shanghai Children's Medical Center,Shanghai Jiaotong University School of Medicine,Department of Biobank,Pediatric Translational Medicine Institute,Shanghai Children's Medical Center,Shanghai Jiaotong University School of Medicine

Clc Number:

Fund Project:

Supported by Science and Technology Innovation Program of Shanghai Jiaotong University School of Medicine (Z2016-02) and Third Stage Biobank Construction Project of "985 Engineer" of Shanghai Jiaotong University.

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Precision Medicine Initiation and "Healthy China 2030" Plan have created a good opportunity for development of biobank. However, it also faces many challenges in the process of building up Chinese biobank, including different standards for biobank, electronic information system and clinical treatment, incomplete laws and regulations, and the obstacles of sustainable development. Unremitting efforts are needed to guide, Chinese biobank development on the right track of standardization, informatization and normalization.

    Reference
    Related
    Cited by
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 10,2017
  • Revised:March 16,2017
  • Adopted:March 28,2017
  • Online: March 31,2017
  • Published:
Article QR Code